$27.56
−0.79%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$27.54
From 52W high−25.85%
Volume1.45M
Market cap$11.53B
P/E (TTM)18.4x
P/S (TTM)1.8x
Div yield1.69%
Key dataSep 18, 2026
Open
$27.54
From 52W high
−25.85%
Volume
1.45M
Market cap
$11.53B
ValuationView details →
P/E (Fwd)
38.8x
EV/EBITDA
10.5x
P/E (TTM)
18.4x
RSI (14)
36.0
MomentumView details →
1D Return
−0.79%
YTD Return
−16.06%
SummaryUpdated Jun 1, 2026
Smith & Nephew plc (NYSE:SNN) is a British multinational medical technology company founded in 1856 and headquartered in Watford, United Kingdom. Originally established as a pharmacy business by Thomas James Smith, the company has evolved over more than 165 years into one of the world's leading medical device manufacturers. Smith & Nephew went public on the New York Stock Exchange in 1999 and today operates globally, serving healthcare providers across established and emerging markets. The company has undergone significant strategic transformation in recent years, implementing a comprehensive 12-point improvement plan to enhance operational efficiency and drive consistent growth across its medical device portfolio.
Similar companies
Latest newsMore news →
Smith+Nephew announced a cash tender offer to purchase up to $250 million of its outstanding 2.032% Senior Notes due 2030.12d agoBlackRock Inc. acquired a new stake of 8,056,801 shares in Smith & Nephew SNATS, Inc., valued at approximately $505.32 million, as disclosed in its Form 13F filing with the SEC.26d ago